KIF18A-IN-1 是一种载脂蛋白 L1 APOL1 的抑制剂，可用于局灶节段性肾小球硬化 (FSGS) 和非糖尿病肾病 (NDKD) 的研究。详细信息请参考专利文献 WO2020131807A1 中的化合物 87。
货号:ajcx39352
CAS:2446817-72-5
分子式:C21H20FN3O3
分子量：381.4
溶解度:DMSO : 125 mg/mL (327.74 mM; Need ultrasonic)
纯度：98%
存储：Store at -20°C
库存：现货

Background:

APOL1-IN-1 is a apolipoprotein L1 (APOL1) inhibitor extracted from patent WO2020131807A1 compound 87. APOL1-IN-1 can be used for the research of focal segmental glomerulosclerosis (FSGS) and non-diabetic kidney disease (NDKD)[1].

[1]. Brodney M, et, al. Inhibitors of apol1 and methods of using same. WO2020131807A1.